title: Mutations in FN1 cause glomerulopathy with fibronectin deposits.
abstract: Glomerulopathy with fibronectin (FN) deposits (GFND) is an autosomal dominant disease with age-related penetrance, characterized by proteinuria, microscopic hematuria, hypertension, and massive glomerular deposits of FN that lead to end-stage renal failure. The genetic abnormality underlying GFND was still unknown. We hypothesized that mutations in FN1, which encodes FN, were the cause of GFND. In a large Italian pedigree with eight affected subjects, we found linkage with GFND at the FN1 locus at 2q32. We sequenced the FN1 in 15 unrelated pedigrees and found three heterozygous missense mutations, the W1925R, L1974R, and Y973C, that cosegregated with the disease in six pedigrees. The mutations affected two domains of FN (Hep-II domain for the W1925R and the L1974R, and Hep-III domain for the Y973C) that play key roles in FN-cell interaction and in FN fibrillogenesis. Mutant recombinant Hep-II fragments were expressed, and functional studies revealed a lower binding to heparin and to endothelial cells and podocytes compared with wild-type Hep-II and an impaired capability to induce endothelial cell spreading and cytoskeletal reorganization. Overall dominant mutations in FN1 accounted for 40% of cases of GFND in our study group. These findings may help understanding the pathogenesis of proteinuria and glomerular FN deposits in GFND and possibly in more common renal diseases such as diabetic nephropathy, IgA nephropathy, and lupus nephritis. To our knowledge no FN1 mutation causing a human disease was previously reported.
authors.affiliation: Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Daccò, Villa Camozzi, Ranica, Bergamo 24020, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Castelletti
authors.forename: Roberta
authors.initials: R
authors.lastname: Donadelli
authors.forename: Federica
authors.initials: F
authors.lastname: Banterla
authors.forename: Friedhelm
authors.initials: F
authors.lastname: Hildebrandt
authors.forename: Peter F
authors.initials: PF
authors.lastname: Zipfel
authors.forename: Elena
authors.initials: E
authors.lastname: Bresin
authors.forename: Edgar
authors.initials: E
authors.lastname: Otto
authors.forename: Christine
authors.initials: C
authors.lastname: Skerka
authors.forename: Alessandra
authors.initials: A
authors.lastname: Renieri
authors.forename: Marta
authors.initials: M
authors.lastname: Todeschini
authors.forename: Jessica
authors.initials: J
authors.lastname: Caprioli
authors.forename: Rosa Maria
authors.initials: RM
authors.lastname: Caruso
authors.forename: Rosangela
authors.initials: R
authors.lastname: Artuso
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Remuzzi
authors.forename: Marina
authors.initials: M
authors.lastname: Noris
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D005353:Fibronectins / Q000737:chemistry / Q000145:classification / Q000235:genetics* / Q000378:metabolism*; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D008958:Models, Molecular; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
chemical_list: D005353:Fibronectins; D011994:Recombinant Proteins